Risk:benefit assessment of old medicines.

about

Gemifloxacin, a fluoroquinolone antimicrobial drug, inhibits migration and invasion of human colon cancer cells

P2860

Q41818545-728BACD2-41BD-4771-8815-F13540BD55F8

P2860

Risk:benefit assessment of old medicines.

Item

http://www.wikidata.org/entity/Q35826523

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Risk:benefit assessment of old medicines.

@ast

Risk:benefit assessment of old medicines.

@en

type

Item

label

Risk:benefit assessment of old medicines.

@ast

Risk:benefit assessment of old medicines.

@en

prefLabel

Risk:benefit assessment of old medicines.

@ast

Risk:benefit assessment of old medicines.

@en

P1476

Risk:benefit assessment of old medicines.

@en

P2093

Silvio Garattini

http://www.w3.org/2001/XMLSchema#string

Vittorio Bertelé

http://www.w3.org/2001/XMLSchema#string

P2860

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting

A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

Dropout rates in randomised antipsychotic drug trials.

Efficacy, safety, and cost of new anticancer drugs.

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study.

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis.

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.

P304

581-586

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.2004.02197.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8164728

http://www.w3.org/2001/XMLSchema#string

P698

15563356

http://www.w3.org/2001/XMLSchema#string

P932

1884643

http://www.w3.org/2001/XMLSchema#string

Risk:benefit assessment of old medicines.

about

P2860

P2860

Risk:benefit assessment of old medicines.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932